MedPath

Exploring the effects of different ways of communicating fracture risk and treatment benefits would influence patients' beliefs of risk of fracture and osteoporosis treatment to reduce their fracture risk.

Not Applicable
Conditions
Osteoporosis
Metabolic and Endocrine - Metabolic disorders
Fracture risk communication
Musculoskeletal - Osteoporosis
Injuries and Accidents - Fractures
Registration Number
ACTRN12613001081707
Lead Sponsor
niversity of Auckland
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

Age >60y (because the Garvan absolute fracture risk calculator does not estimate fracture risk for younger participants).

Exclusion Criteria

Patients taking antiresorptive treatment for osteoporosis.
Unable to complete the questionnaires, for language or cognitive reasons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath